atorvastatin has been researched along with neopterin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchs, D; Laich, A; Neurauter, G; Schennach, H; Weiss, G; Wirleitner, B | 1 |
| Frick, B; Fuchs, D; Schroecksnadel, K; Weiss, G; Winkler, C; Wirleitner, B | 1 |
| Gans, RO; May, JF; Mulder, DJ; Smit, AJ; Tervaert, JW; van Doormaal, JJ; van Haelst, PL; Wobbes, MH; Zijlstra, F | 1 |
| Braunwald, E; Cannon, CP; Morrow, DA; Ray, KK; Rifai, N; Sabatine, MS; Shui, A | 1 |
| Critchfield, J; Deeks, SG; Lee, E; Lollo, N; Price, RW; Probasco, JC; Spudich, SS | 1 |
| Braunwald, E; Cannon, CP; Morrow, DA; Nazer, B; Ray, KK; Scirica, B; Sloan, S | 1 |
| Arsenault, BJ; DeMicco, DA; Kastelein, JJ; Kohli, P; Lambert, G; Laskey, R; Messig, MM; Waters, DD | 1 |
4 trial(s) available for atorvastatin and neopterin
| Article | Year |
|---|---|
The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress.
Topics: Adult; Aged; Antibodies; Atorvastatin; Biomarkers; C-Reactive Protein; Cell Adhesion Molecules; Cholesterol, LDL; Coronary Artery Disease; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipoproteins, LDL; Male; Middle Aged; Neopterin; Oxidative Stress; Pyrroles; Simvastatin; von Willebrand Factor | 2007 |
Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome.
Topics: Acute Disease; Anti-Infective Agents; Anticholesteremic Agents; Atorvastatin; Biomarkers; Coronary Artery Disease; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Monocytes; Neopterin; Pravastatin; Prognosis; Pyrroles; Risk Factors; Secondary Prevention; Survival Analysis | 2007 |
Failure of atorvastatin to modulate CSF HIV-1 infection: results of a pilot study.
Topics: Adult; Anti-HIV Agents; Atorvastatin; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Heptanoic Acids; HIV Infections; HIV-1; Humans; Male; Neopterin; Pilot Projects; Pyrroles; Viral Load | 2008 |
Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Heart Failure; Heptanoic Acids; Hospitalization; Humans; Male; Middle Aged; Neopterin; Pravastatin; Proportional Hazards Models; Pyrroles; Sensitivity and Specificity; Treatment Outcome | 2011 |
3 other study(ies) available for atorvastatin and neopterin
| Article | Year |
|---|---|
Atorvastatin suppresses interferon-gamma -induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines.
Topics: Atorvastatin; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-gamma; Leukocytes, Mononuclear; Monocytes; Neopterin; Pyrroles; Tryptophan | 2003 |
Atorvastatin suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells.
Topics: Anti-Inflammatory Agents; Atorvastatin; Cardiovascular Diseases; Concanavalin A; Dose-Response Relationship, Drug; Heptanoic Acids; Homocystine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocytes, Mononuclear; Neopterin; Oxidative Stress; Phytohemagglutinins; Pyrroles | 2005 |
Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study).
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adiponectin; Aged; Atorvastatin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; CD40 Ligand; Chemokine CCL2; Coronary Artery Disease; Cystatin C; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Insulin; Intercellular Adhesion Molecule-1; Lipoprotein(a); Male; Matrix Metalloproteinase 9; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Neopterin; Osteopontin; Peptide Fragments; Peroxidase; Randomized Controlled Trials as Topic; Receptor for Advanced Glycation End Products; Risk Factors; Secondary Prevention; Vascular Cell Adhesion Molecule-1; Vitamin D | 2016 |